|
Author, publication’s year [ref] | Patient’s sex and age (years) | Underlying conditions | WBC (×109/L) | PMN (×109/L) | Classification | Species | Treatment | Outcome | Cause of death |
|
Kuo et al. 1996 [91] | M, 44 | Peripheral T-cell lymphoma, CHTH | 0.7 | 0.3 | Ulcerative and plaque-like tracheobronchitis | Aspergillus fumigatus | Amphotericin B followed by itraconazole | Survived | |
Sancho et al. 1997 [65] | M, 43 | Acute lymphoblastic leukemia, CHTH | 3.2 | 1.6 | Multiple white nodules, inflammatory bronchial stenosis | Aspergillus sp. | Amphotericin B | Died | Disseminated aspergillosis, massive hemoptysis |
Arriero et al. 1998 [67] | F, 64 | Acute lymphoblastic leukemia, CHTH, diabetes | 7.0 | 4.7 | Pseudomembranous and obstructing tracheobronchitis | Aspergillus flavus | Amphotericin B | Died | Respiratory failure |
Machida et al. 1999 [70] | F, 44 | Chronic myelogenous leukemia | NA | 5.0 | Necrotic pseudomembranes | NA | Amphotericin B | Died | Respiratory failure |
Ahn et al. 2000 [38] | M, 56 | Acute myeloid leukemia, CHTH | 0.3 | NA | Pseudomembranous tracheobronchitis | Aspergillus sp. | Amphotericin B | Died | Massive hemoptysis |
Tasci et al. 2000 [92] | F, 54 | Plasma cell myeloma, CHTH, autologous HSCT | NA | 0.1 | Multiple white plaques, pseudomembranes, mucous plugs | Aspergillus fumigatus | Amphotericin B | Died | Sepsis, respiratory failure |
Van Assen et al. 2000 [69] | F, 56 | Acute myeloid leukemia, CHTH, allogeneic HSCT, GvHD, immunosuppressive therapy | NA | NA | Plaques, ulcerations, pseudomembranes | Aspergillus fumigatus | Amphotericin B i.v. plus nebulization liposomal amphotericin B plus itraconazole | Died | Respiratory failure |
Koh et al. 2000 [93] | M, 20 | Leukemia, HSCT, GvHD, immunosuppresive therapy | NA | NA | Pseudomembranous tracheobronchitis | Aspergillus fumigatus | NA | Died | Respiratory failure |
Routsi et al. 2001 [94] | M, 60 | Erythroleukemia, CHTH | Pancytopenia | NA | Bronchial obstruction by mass containing Aspergillus hyphae | Aspergillus fumigatus | Amphotericin B | Died | Septic shock |
Buchheidt et al. 2003 [68] | F, 55 | Hodgkin lymphoma, CHTH | 3.0 | 2.6 | Ulcerations, plaque-like lesions and pseudomembranes | Aspergillus fumigatus | Amphotericin B, liposomal Amphotericin B | Survived | |
Irani et al. 2003 [39] | M, 40 | Low-grade non-Hodgkin lymphoma, allogeneic HSCT, severe GvHD, immunosuppressive therapy | NA | NA | Multiple papular and plaque-like, vascularized mucosal lesions | Aspergillus fumigatus | NA | NA | |
Routsi et al. 2004 [72] | F, 22 | Lymphom, CHTH | 0.21 | NA | Pseudomembranes, bronchial obstruction | Aspergillus terreus | Liposomal amphotericin B plus voriconazole | Died | Respiratory failure |
Tasci et al. 2006 [45] | M, 58 | Plasma cell myeloma, CHTH | NA | 0.4 | Multiple circumscribed lesions, pseudomembranes | Aspergillus fumigatus | Liposomal amphotericin B | Died | Septic shock |
F, 64 | Burkitts’ lymphoma, CHTH | Pancytopenia | | Pseudomembranes | Aspergillus fumigatus | Amphotericin B | Died | Respiratory failure |
M, 34 | Burkitts’ lymphoma, CHTH | NA | NA | Pseudomembranes | Aspergillus fumigatus | Amphotericin B plus caspofungin | Died | Initial improvement in ITBA but lymphoma progression, fatal intracranial bleeding |
Onozawa et al. 2009 [95] | M, 49 | Angioimmunoblastic T-cell lymphoma | NA | NA | Pseudomembranous cream-coloured plaques | Aspergillus fumigatus | Inhaled amphotericin B plus oral voriconazole | Survived | |
Casal et al. 2009 [71] | M, 65 | Chronic lymphocytic leukemia, allogeneic HSCT, | NA | 4.0 | Bronchial narrowing with necrotic and friable mucosa | NA | Liposomal amphotericin B plus posaconazole | Survived | |
Krenke et al. 2009 [66] | M, 63 | Acute myeloid leukemia, CHTH | 0.5 | <0.1 | Ulcerative lesions and pseudomembranes | Aspergillus sp. | Voriconazole | Died | Respiratory failure, pulmonary embolism |
Patel et al. 2010 [17] | M, 73 | Non-Hodgkin lymphoma, CHTH | 15.9 | NA | Plaques forming pseudomembranes, ulcerations | Aspergillus fumigatus | Voriconazole | Died | Respiratory failure |
|